The head of the Catholic Church, Pope Francis, passed away on Easter Monday, less than one month after releasing a video revealing his prayer intention for April in which he requests prayers that new technologies, including those used in healthcare, will not replace human relationships.
"It is true technology is the fruit of the intelligence God gave us, but we need to use it well. It can't...
Technology company Leidos is pouring $10 million into a plan to use AI to detect and manage diseases.
The company is working with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE) on a five-year plan to develop AI-powered tools for faster detection of diseases, including heart disease and cancer, as well as reduced diagnostic turnaround times, allowing...
Podimetrics, a company that helps patients with diabetes prevent serious complications, is teaming up with HealthMed, an employee health and wellness platform.
HealthMed aims to integrate Podimetrics' SmartMat technology into its portfolio of benefits intended for large employers, hospitals and municipalities. The company also provides employee wellness and mental health programs.
Podimetrics'...
Data from the J.D. Power 2025 U.S. Healthcare Digital Experience Study revealed that health insurance members enrolled in health plans and Medicare Advantage plans use their plan websites and mobile apps as their primary means of communication, but the quality of these digital experiences lags behind that of other industries.
In the study, Cigna Healthcare ranked highest in satisfaction among...
Editor's note: This article has been updated to clarify that MCCPDC's partnership with Wheel began in 2024.
Specialty pharmaceutical distributor Morris & Dickson is partnering with Mark Cuban Cost Plus Drug Company (MCCPDC) and the Cost Plus Marketplace to ensure access to vital injectable medications.
MCCPDC offers consumers a broad range...
Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines.
The de novo classification is for the company’s CT-132 offering, for which it received FDA Breakthrough Device Designation in 2022.
CT-132 is intended for the preventive treatment of episodic migraines in patients 18...
Home care cancer-focused platform Reimagine Care announced it is joining forces with healthcare system MedStar Health to integrate its on-demand oncology care platform into the health system's cancer care delivery model and assist patients with the transition from in-clinic care to the home.
Reimagine Care's patient-centered model provides patients with customized all-inclusive care from their...
Phantom Neuro, a neurotechnology company that offers a muscle-machine interface for controlling prosthetic limbs and robotic exoskeletons, announced an oversubscribed $19 million Series A funding round, bringing its total raise to $28 million.
Ottobock led the round with participation from existing investors Draper Associates, Time BioVentures, Breakout Ventures, Risk and Return, and LionBird...
Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes.
G7 15 Day, scheduled to launch in the second half of this year, will have a 15.5-day wear time (including a 12-hour grace period) and last 15% longer than Dexcom G7, according to the company. ...
Editors note: This article has been updated with content from Bliss.
Bliss Aesthetics, a company that connects patients to plastic surgeons, announced it secured $17.5 million in seed funding.
Shine Capital led the round, with participation from Synchrony Ventures, Sheva Ventures, Point72 Ventures and Cerca Partners.
WHAT IT DOES
Bliss Aesthetics matches patients to board-certified plastic...
